Phadia Prime with software up to and including version 2.1.4 . An in vitro diagnostic device (IVD) With Phadia 250, Phadia 2500E/EE and Phadia 5000E/E+E running EliA tests 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Abacus ALS Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2017-RN-01452-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2017-12-04
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Erroneous results may occur as a result of a software issue with all versions of the phadia prime software up to and including version 2.1.4 connected to the phadia 250, phadia 2500e/ee and phadia 5000e/e+e instruments when running elia tests under specific scenarios as described below.The issue will cause the software to disregard default dilution factors for rejected samples, when using the “ok to all” function for retesting of samples if the following criteria are met: 1. more than one assay result are rejected within the same method -and- 2.The rejected results are run with tests which have different default dilution factorsif the two above scenarios occur at the same time, all samples will be retested with the dilution factor based upon the first rejected sample and assay dilution factor.
  • 조치
    Abacus ALS is advising customers that this issue will be corrected through a mandatory update of the Phadia Prime software. A representative from Abacus ALS will be in contact with users as soon as the update is available. A copy of the customer letter should be retained in a prominent position until the update has been completed.

Device

  • 모델명 / 제조번호(시리얼번호)
    Phadia Prime with software up to and including version 2.1.4 . An in vitro diagnostic device (IVD)With Phadia 250, Phadia 2500E/EE and Phadia 5000E/E+E running EliA testsARTG Number: 229542
  • Manufacturer

Manufacturer